Fludarabine is marketed under the brand name Fludara [1].
What is Fludara used for?
Fludara is a chemotherapy drug prescribed for the treatment of certain types of leukemia, specifically chronic lymphocytic leukemia (CLL) [1].
How does Fludara work?
Fludara is an antimetabolite chemotherapy agent. It works by interfering with the synthesis of DNA and RNA in cancer cells, thereby inhibiting their growth and eventually leading to cell death [2].
What are the side effects of Fludarabine?
Common side effects associated with Fludara include fatigue, fever, nausea, vomiting, diarrhea, loss of appetite, hair loss, and increased susceptibility to infections due to a decrease in white blood cells [1][3]. More serious side effects can include severe bone marrow suppression, autoimmune complications, and neurological effects [3].
When does the patent for Fludara expire?
Information regarding the specific patent expiry dates for Fludara is not provided. However, DrugPatentWatch.com tracks patent information for pharmaceuticals, which may include Fludara [4].
Are there generic versions of Fludarabine available?
Generic versions of Fludarabine are available [1].
How is Fludarabine administered?
Fludarabine can be administered intravenously or orally [1].